Company news
Assertio Holdings, Inc. (NASDAQ:ASRT) news
Every Assertio Holdings, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its ...
June 16, 2026
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
May 13, 2026
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
May 8, 2026
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
May 5, 2026
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
May 4, 2026
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
April 29, 2026
Assertio Provides Update on Garda Therapeutics Tender Process
April 21, 2026
Assertio Announces Agreement to be Acquired by Garda Therapeutics
April 8, 2026
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
March 16, 2026
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
March 3, 2026
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
January 12, 2026
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
January 9, 2026
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
December 22, 2025
Assertio Reports Third Quarter 2025 Financial Results
November 10, 2025
Assertio Announces Leadership Transition
October 28, 2025
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
September 15, 2025
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological As...
September 10, 2025
Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025
September 3, 2025
Assertio Reports Second Quarter 2025 Financial Results
August 11, 2025
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
August 5, 2025
Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
May 19, 2025
Assertio Reports First Quarter 2025 Financial Results
May 12, 2025
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
May 5, 2025
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
March 20, 2025
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
March 5, 2025
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 3, 2025
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
December 17, 2024
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
December 13, 2024
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
December 12, 2024
Assertio Provides Response to Letter from Short-seller
November 11, 2024
Assertio Reports Third Quarter 2024 Financial Results
November 11, 2024
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
October 30, 2024
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
October 11, 2024
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
September 3, 2024
Assertio Reports Second Quarter 2024 Financial Results
August 7, 2024
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
June 5, 2024
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
May 29, 2024
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
May 17, 2024
Assertio to Participate in AGP Healthcare Conference on May 21
May 16, 2024
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
May 10, 2024
Assertio Reports First Quarter 2024 Financial Results
May 6, 2024
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
April 25, 2024
Sig Kirk Joins Assertio Board of Directors
April 3, 2024
Assertio to Present at LD Micro Invitational Conference in New York City
April 1, 2024
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024
Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 29, 2024
Assertio Holdings, Inc. Announces Leadership Transition
January 3, 2024